Brief report · 29 Dec 2025
Conference abstractPublished 24 Sep 2014
Cross linkers for heart valve tissue engineering
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Currently, an effective cross linking reagent to treat xenogenic decellularized heart valve matrices is lacking. Matrices still elicit an intense cell-mediated immune response and calcification. The aim of this study was to evaluate the cross linking effect of Quercetin, Catechin, Caffeic Acid and Tannic acid on porcine aortic valve matrices. Materials and methods: Cytotoxicity of the different cross linkers was evaluated. Mechanical properties of cross linked porcine matrices and control matrices (non-fixed) were examined by tensile strength testing. Cytocompatibility of the fixed matrices was examined. Cross linked and control matrices were implanted subcutaneously in Wistar rats (n=9). After 2 weeks the explants were examined by light microscopy. Calcium content was determined using inductively coupled plasma-mass spectrometry. Antibody reaction against porcine tissue in the rat serum was determined. Results: Cytotoxicity studies demonstrated that cross linkers, even at high concentrations, did not inhibit cell viability. All cross linkers, except Tannic acid, improve mechanical strength of acellular porcine matrices. Moreover, tensile strength of Quercetin fixed matrices was comparable with glutaraldehyde-fixed leaflets. Light microscopic evaluation showed that cross linked matrices showed only a mild lymphocytic inflammatory reaction. Furthermore, Quercetin fixed leaflets exhibited a well preserved matrix without infiltration of CD3+ cells. Calcium levels after 2 weeks were for controls (non-fixed): 206.33μg/mg; Quercetin: 151.33μg/mg; Catechin: 181μg/mg and Caffeid acid fixed matrices: 163.66μg/mg. Conclusion: Quercetin is the most suitable candidate for heart valve cross linking and could be used as alternative for glutaraldehyde. Whether, Quercetin allows for autologous cell repopulation in order to create a viable tissue engineered heart valve still needs to be investigated
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Tissue Science and Engineering.
Opinion · 29 Dec 2025
Biomaterials, Cells, And Stimulation For Spinal Cord Repair
Brief report · 29 Dec 2025
Cardiac Tissue Engineering: Building a New Heart
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tissue Science and Engineering
- SubjectEngineering
- BylineArticles whose byline prints “Somers Pamela”

